The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Endocrine Disruptor Vinclozolin Induced Epigenetic Transgenerational Adult-Onset Disease
Open accessAbstract
The fetal basis of adult disease is poorly understood on a molecular level and cannot be solely attributed to genetic mutations or a single etiology. Embryonic exposure to environmental compounds has been shown to promote various disease states or lesions in the first generation (F1). The current study used the endocrine disruptor vinclozolin (antiandrogenic compound) in a transient embryonic exposure at the time of gonadal sex determination in rats. Adult animals from the F1 generation and all subsequent generations examined (F1-F4) developed a number of disease states or tissue abnormalities including prostate disease, kidney disease, immune system abnormalities, testis abnormalities, and tumor development (e.g. breast). In addition, a number of blood abnormalities developed including hypercholesterolemia. The incidence or prevalence of these transgenerational disease states was high and consistent across all generations (F1-F4) and, based on data from a previous study, appears to be due in part to epigenetic alterations in the male germ line. The observations demonstrate that an environmental compound, endocrine disruptor, can induce transgenerational disease states or abnormalities, and this suggests a potential epigenetic etiology and molecular basis of adult onset disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chang, H., Anway, M. D., Rekow, S. S., & Skinner, M. K. (2006) · Endocrinology · doi:10.1210/en.2006-0987 · Cited by 148
Self-citationRetractedJemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility
Anway, M. D., Cupp, A. S., Uzumcu, M., & Skinner, M. K. (2005) · Science · doi:10.1126/science.1108190 · Cited by 2,563
Self-citationGenomic imprinting: parental influence on the genome
Reik, W., & Walter, J. (2001) · Nature Reviews Genetics · doi:10.1038/35047554 · Cited by 2,285
Epigenetic reprogramming in mouse primordial germ cells
Hajkova, P., Erhardt, S., Lane, N., Haaf, T., El-Maarri, O., Reik, W., Walter, J., & Surani, M. A. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00181-8 · Cited by 1,191
Developmental origins of disease paradigm: A mechanistic and evolutionary perspective
Gluckman, P. D., & Hanson, M. A. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000135998.08025.fb · Cited by 607
Kelce, W. R., Monosson, E., Gamcsik, M. P., Laws, S. C., & Gray, L. E. (1994) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1994.1117 · Cited by 542
An integrated epigenetic and genetic approach to common human disease
BJORNSSON, H. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.06.009 · Cited by 448
Fisher, J. S. (2004) · Reproduction · doi:10.1530/rep.1.00025 · Cited by 427
Epidemiology of male breast cancer
Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A. (2020) · The Breast · doi:10.1016/j.breast.2020.08.010 · Cited by 411
Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats
Drake, A. J., Walker, B. R., & Seckl, J. R. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00106.2004 · Cited by 410
Ostby, J., Monosson, E., Kelce, W. R., & Gray, L. E. (1999) · Toxicology and Industrial Health · doi:10.1177/074823379901500106 · Cited by 331
Epidemiology of Male Breast Cancer
Weiss, J. R., Moysich, K. B., & Swede, H. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.20.14.1 · Cited by 328
Zambrano, E., Martínez‐Samayoa, P. M., Bautista, C. J., Deás, M., Guillén, L., Rodríguez‐González, G. L., Guzmán, C., Larrea, F., & Nathanielsz, P. W. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.086462 · Cited by 325
Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
Newbold, R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.9.1655 · Cited by 202
Barber, R., Plumb, M. A., Boulton, E., Roux, I., & Dubrova, Y. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102015399 · Cited by 202
Declining gonadal function in elderly men
Kaufman, J. M., & Vermeulen, A. (1997) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(97)80302-3 · Cited by 181
Characterization of the period of sensitivity of fetal male sexual development to vinclozolin
Wolf, C. J. (2000) · Toxicological Sciences · doi:10.1093/toxsci/55.1.152 · Cited by 168
Uzumcu, M., Suzuki, H., & Skinner, M. K. (2004) · Reproductive Toxicology · doi:10.1016/j.reprotox.2004.05.008 · Cited by 146
Self-citationRenal Failure Secondary to Acute Tubular Necrosis
Gill, N., Nally, J. V., & Fatica, R. A. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2847 · Cited by 120
Majdič, G., Millar, M. R., & Saunders, P. T. K. (1995) · Journal of Endocrinology · doi:10.1677/joe.0.1470285 · Cited by 112
Pluripotential stem cells derived from migrating primordial germ cells
Durcova‐Hills, G., Ainscough, J., & McLaren, A. L. D. (2001) · Differentiation · doi:10.1046/j.1432-0436.2001.680409.x · Cited by 104
Ovarian Carcinoma in an Adolescent With Transgenerational Exposure to Diethylstilbestrol
Blatt, J., Le, L. V., Weiner, T. M., & Sailer, S. L. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200308000-00009 · Cited by 96
Hotchkiss, A. K., Ostby, J. S., Vandenburgh, J. G., & Gray, L. E. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s3435 · Cited by 82
Pre- and postnatal oral toxicity of vinclozolin in Wistar and Long-Evans rats
Hellwig, J., van Ravenzwaay, B., Mayer, M., & Gembardt, C. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1400 · Cited by 73
Cupp, A. S., Uzumcu, M., Suzuki, H., Dirks, K. A., Phillips, B., & Skinner, M. K. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02736.x · Cited by 68
Self-citationForan, C. M. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.2.389 · Cited by 63
Colbert, N. K. W., Pelletier, N. C., Cote, J. M., Concannon, J. B., Jurdak, N. A., Minott, S. B., & Markowski, V. P. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7509 · Cited by 60 · cited 1×
“For vinclozolin, the lowest observed adverse effect level recommended is 11 mg/kg d, but doses at the 1 mg/ kg d have biological effects (31).”
BackgroundThe fetal basis of adult disease: Role of environmental exposures?introduction
Heindel, J. J. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20119 · Cited by 56
Breast cancer control: Signs of progress, but more work required
Boyle, P. (2005) · The Breast · doi:10.1016/j.breast.2005.10.001 · Cited by 55
Turner, K. J., Mcintyre, B., Phillips, S. L., Barlow, N. J., Bowman, C., & Foster, P. M. D. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg096 · Cited by 53
Epidemiologic risk factors for chronic prostatitis
Ku, J. H., Kim, S. W., & Paick, J. (2005) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00560.x · Cited by 32
Dong, H., Bonala, R., Suzuki, N., Johnson, F., Grollman, A. P., & Shibutani, S. (2004) · Biochemistry · doi:10.1021/bi0482194 · Cited by 31
Corwin, E. J. (2004) · Biological Research For Nursing · doi:10.1177/1099800404264779 · Cited by 28
Expression of androgen receptors in upper human fetal reproductive tract
Sajjad, Y. (2004) · Human Reproduction · doi:10.1093/humrep/deh295 · Cited by 20
Developmental stage sensitivity and mode of action information for androgen agonists and antagonists
Euling, S. Y., & Kimmel, C. A. (2001) · The Science of The Total Environment · doi:10.1016/s0048-9697(01)00736-7 · Cited by 18
Cited by
Environmental epigenomics and disease susceptibility
Jirtle, R. L., & Skinner, M. K. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2045 · Cited by 2,492
Self-citationBisphenol A and human health: A review of the literature
Rochester, J. R. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.08.008 · Cited by 2,018
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Evolution, the Extended Synthesis
(2010) · The MIT Press eBooks · doi:10.7551/mitpress/9780262513678.001.0001 · Cited by 964
Bollati, V, & Baccarelli, A. (2010) · Heredity · doi:10.1038/hdy.2010.2 · Cited by 590
Metadata
- Authors
- Anway, M. D., Leathers, C., & Skinner, M. K.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-12
- Volume
- 147
- Issue
- 12
- Pages
- 5515-5523
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2162989712
- Cited by
- 555
- References
- 38
- FWCI
- 19.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.